X0306 4 2017-02-07 0 0001641640 Nabriva Therapeutics AG NBRV 0001289946 Broom Colin MD 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 Chief Executive Officer Stock Option 2017-02-07 4 A 0 26100 0.00 A 2027-02-06 Common Shares 26100 26100 D The exercise price is 79.63 Euro. This option was granted on February 7, 2017. Vesting will begin on February 28, 2017 and end on February 28, 2021. Twenty-five percent (25%) of the option will vest on February 28, 2018, and the remaining seventy-five percent (75%) will vest on a monthly pro-rata basis over the remaining vesting period. /s/ Gary L. Sender, by power of attorney 2017-02-09